Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

Thursday, August 15, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

AETHLON MEDICAL, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

For the three month periods ended June 30, 2019 and 2018

Three Months

Three Months

Ended 6/30/19

Ended 6/30/18

Government contract revenue

$30,000

$149,625

OPERATING COSTS AND EXPENSES

Professional fees

607,578

449,435

Payroll and related

605,995

602,565

General and administrative

382,615

194,897

1,596,188

1,246,897

OPERATING LOSS

(1,566,188)

(1,097,272)

OTHER (INCOME) EXPENSE

Loss on debt extinguishment

447,011

-

Interest and other debt expenses

54,085

55,104

501,096

55,104

NET LOSS 

$(2,067,284)

$(1,152,376)

Loss attributable to noncontrolling interests

(860)

(6,148)

NET LOSS ATTRIBUTABLE TO AETHLON MEDICAL, INC.

$(2,066,424)

$(1,146,228)

Basic and diluted net loss available to  common stockholders per share

$             (0.11)

$             (0.06)

Weighted average number of common shares outstanding

19,057,255

17,754,728



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store